投资协议项下的交易将使目标公司能够筹措资金并将减少目标公司对集团财务资源的依赖。投资协议项下的交易可使目标公司以较低的成本优化其财务结构，以支持其后续业务发展。公司认为，引入市场上信誉良好的投资者（如投资者），可提高投资者对集团的信心，为集团良好的财务状况带来更多融资选择。Green First Hydrocolloid (01084.HK) announced on October 31, 2024 that investors Zhangzhou Longhai Industrial Investment Co., Ltd., Green First (indirect wholly-owned subsidiary), Xiamen Xunyi Cai, and Mr. Wengwu Yin entered into an investment agreement, whereby investors agreed to inject up to RMB 63.85 million into the target company Xiamen Blue Algae Film Biotechnology Co., Ltd., and Green First also agreed to inject RMB 27.77 million into the target company at the same time.
According to the investment agreement, investors have been granted a repurchase option, under which, in the event of any redemption event, Green First shall buy back all shares of the investors in the target company at the repurchase price.
The target company is a limited company established in China, as of the date of this announcement, owned 60%, 30%, and 10% respectively by Green First, Xiamen Xunyi Cai, and Mr. Weng. The target company is mainly engaged in the research, manufacturing, and sales of biodegradable biopolymer films, as feasible alternatives for plastic applications.
The transactions under the investment agreement will enable the target company to raise funds and reduce its reliance on group financial resources. The transactions under the investment agreement can optimize the target company's financial structure at a lower cost to support its subsequent business development. The company believes that bringing in reputable investors (such as investors) from the market can boost investor confidence in the group and provide more financing options for the group's sound financial condition.
